Proof of Concept: Microinvasive AngioVac Approach in Renal Cell Carcinoma With Atrial Thrombosis

Ann Thorac Surg. 2021 Sep;112(3):e193-e196. doi: 10.1016/j.athoracsur.2020.11.093. Epub 2021 Mar 4.

Abstract

The AngioVac system (AngioDynamics, Latham, NY) has already been described for treatment of thrombotic formations concerning the venous district and the tricuspid valve. We describe an innovative application of the AngioVac system to treat the inferior vena cava thrombosis associated with renal cell carcinoma. In a high surgical risk patient, we utilized a microinvasive and a modified venoarterial AngioVac circuit to remove the atrial thrombus, ensure temporary circulatory support during abdominal surgery, and prevent pulmonary embolism.

Publication types

  • Case Reports
  • Video-Audio Media

MeSH terms

  • Aged
  • Carcinoma, Renal Cell / secondary*
  • Carcinoma, Renal Cell / surgery
  • Heart Diseases / etiology*
  • Heart Diseases / surgery*
  • Humans
  • Kidney Neoplasms / pathology*
  • Kidney Neoplasms / surgery
  • Male
  • Neoplastic Cells, Circulating*
  • Nephrectomy
  • Proof of Concept Study
  • Suction
  • Thrombosis / etiology*
  • Thrombosis / surgery*
  • Vena Cava, Inferior*